Firm: HWL Ebsworth (Eagle Health Holdings Limited)
Deal: Eagle Health Holdings Limited (EHH) has been advised on its initial public offering and listing on the Australian Securities Exchange (ASX).
Value: $25 million
Key players: The legal team advising EHH was led by HWL Ebsworth corporate partner Thomas Kim and special counsel David Woodford.
Deal significance: According to a statement from HWL Ebsworth, EHH is a vertically integrated nutritional products business that aims to help people live healthier lives by developing, manufacturing, marketing and distributing a range of health food products and nutritional and dietary supplements under its own brand in China.
The firm explained that EHH distributes its products through a broad range of channels, including pharmacies, health food stores, trading companies, supermarkets and online channels, covering 23 provinces and autonomous regions throughout China.
“In Australia, EHH is seeking to add to its product portfolio by sourcing Australian-manufactured nutritional products and ingredients to export to China,” the firm’s statement read.
“EHH’s ASX listing further strengthens HWL Ebsworth’s capital markets practice, and in particular, its Asian capability by facilitating Asian inbound and outbound investment.”
Shares in EHH began trading on 3 July 2017 under the ASX code EHH. At listing, EHH had a market capitalisation of $125 million based on its offer price of $0.40 per share.